EPRX 6-K: SEC filing
Eupraxia Pharmaceuticals
Filed with the SEC on · accession 0001193125-26-455405
EPRX filed a 6-K (foreign company report) with the SEC on Nov 10, 2026. How foreign companies listed in the US report news and events — like an 8-K for them. The stock moved +2.8% by the first close after the filing.
Summary of the filing
Eupraxia Pharmaceuticals filed its Form 6-K containing condensed consolidated interim financial statements and MD&A for the three and nine months ended September 30, 2026, along with a press release and CEO/CFO certifications.
Key details
How EPRX stock reacted
Close before
$7.42
Nov 9, 2026
First close after
+2.83%
$7.63
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for EPRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EPRX?
Click hereFrequently asked questions
What did EPRX file with the SEC on Nov 10, 2026?
EPRX filed a 6-K (SEC filing). Eupraxia Pharmaceuticals filed its Form 6-K containing condensed consolidated interim financial statements and MD&A for the three and nine months ended September 30, 2026, along with a press release and CEO/CFO certifications.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did EPRX stock react to this filing?
EPRX closed at $7.42 before the filing and $7.63 on Nov 10, 2026 (+2.83%).
Other EPRX SEC filings
Get alerts when EPRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days